Impact of China’s Low Centralized Medicine Procurement Prices on the Cost-Effectiveness of Statins for the Primary Prevention of Atherosclerotic Cardiovascular Disease

BACKGROUND: Statin medications reduce the risk of atherosclerotic cardiovascular disease (ASCVD). China’s new central government medicine procurement policy lowered statin prices by five-fold or more, which may impact the cost-effectiveness of statin therapy. OBJECTIVE: To explore the impact of Chin...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Miao, Liu, Jing, Bellows, Brandon K., Qi, Yue, Sun, Jiayi, Liu, Jun, Moran, Andrew E., Zhao, Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427664/
https://www.ncbi.nlm.nih.gov/pubmed/32923337
http://dx.doi.org/10.5334/gh.830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7427664/
https://www.ncbi.nlm.nih.gov/pubmed/32923337
http://dx.doi.org/10.5334/gh.830

Ejemplares similares